Colossal Biosciences, the world's first de-extinction company, has today announced $200M in a Series C financing by TWG ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new milestone.

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

Cerebras Systems has teamed with Mayo Clinic to create an AI genomic foundation model that predicts the best medical treatments.

The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

Sanctuary on the Moon’ is a lunar time capsule that provides a detailed guide to life on Earth for our future selves.

The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.

And yet, data science is now poised to usher in a level and acceleration of progress that even life sciences have never ...

Illumina and Regeneron are taking stakes in the health data company Truveta to help fund research that may dwarf the efforts ...

Anticipated 2025 milestones include: declare two in vivo development candidates, one in HSCs and one in liver; present further in vivo HSC data; present in vivo data in one liver indication; establish ...